Khang & Khang LLP announces that it is investigating claims of potential
misrepresentations by ConforMIS, Inc. (“ConforMIS” or the “Company”)
(NASDAQ: CFMS).
The investigation focuses on whether the Company and its officers
violated securities laws by issuing misleading information to investors.
If you purchased shares of ConforMIS during the Class Period, please
contact Joon M. Khang, Esquire, of Khang & Khang, 18101 Von Karman
Avenue, 3rd Floor, Irvine, CA 92612, by telephone: (949) 419-3834, or by
e-mail at joon@khanglaw.com.
There has been no class certification in this case. Until certification
occurs, you are not represented by an attorney. You may choose to take
no action and remain a passive class member.
The investigation concerns whether the Company violated the Securities
Exchange Act of 1934. On August 31, 2015, pre-market, ConforMIS
announced that it has initiated a voluntary recall of specific serial
numbers of patient-specific instrumentation for certain of its knee
replacement product systems, in response to recent complaints of
moisture on the instrumentation. A total of approximately 950
patient-specific instrumentation sets are affected by this recall.
If you wish to learn more about this lawsuit, or if you have any
questions concerning this notice or your rights, please contact Joon M.
Khang, a prominent litigator for almost two decades, by telephone: (949)
419-3834, or by e-mail at joon@khanglaw.com.
This press release may constitute Attorney Advertising in some
jurisdictions.
View source version on businesswire.com: http://www.businesswire.com/news/home/20150901006779/en/
Copyright Business Wire 2015